日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer

FDA批准摘要:帕博利珠单抗用于治疗HER2阳性胃癌

Casak, Sandra J; Zhang, Yiming; Song, Chi; Mishra-Kalyani, Pallavi S; Tang, Shenghui; Auth, Doris; de Claro, R Angelo; Pazdur, Richard; Lemery, Steven J

FDA Approval Summary: Tarlatamab for the Treatment of Extensive-Stage Small Cell Lung Cancer

FDA批准摘要:Tarlatamab用于治疗广泛期小细胞肺癌

Liu, Yufan; Nashed, Jeannette; Barone, Amy K; Yuan, Mengdie; Amatya, Anup K; Xiang, Yue; Zhao, Hong; Bi, Youwei; Pegues, Melissa A; Miller, Claudia P; Lane, Ashley R; Mixter, Bronwyn D; Tang, Shenghui; Pazdur, Richard; de Claro, R Angelo; Larkins, Erin

Brazil's health tax at a crossroads: safeguarding the constitutional victory against ultra-processed foods

巴西的健康税正处于十字路口:捍卫宪法赋予的抵制超加工食品的胜利

Neves, Felipe Silva; Mendes, Larissa Loures; Nilson, Eduardo Augusto Fernandes; Castro, Inês Rugani Ribeiro de; Claro, Rafael Moreira; Canella, Daniela Silva; Machado, Ísis Eloah; Carmo, Ariene Silva do; Menezes, Mariana Carvalho de; Malta, Deborah Carvalho

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

美国食品药品监督管理局批准摘要:伊美替司他用于治疗部分低危至中危-1型骨髓增生异常综合征伴输血依赖性贫血患者

Kim, Nina; Pulte, E Dianne; Ehrlich, Lori A; Ionan, Alexei C; Haupert, Spencer; Vallejo, Jonathon; Green, Francis; Zheng, Nan; Wang, Yun; Liu, Jiang; Blanco, Javier G; Dorff, Sarah E; Booth, Brian; Choe, Moran; Gehrke, Brenda; Bhatnagar, Vishal; Theoret, Marc; Pazdur, Richard; De Claro, R Angelo; Norsworthy, Kelly J

FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation

FDA批准摘要:奥鲁西地尼用于治疗伴有异柠檬酸脱氢酶1突变的复发或难治性急性髓系白血病成人患者

Woods, Ashley C; Norsworthy, Kelly J; Choe, Moran; Gehrke, Brenda J; Chen, Haiyan; Vallejo, Jonathon; Pan, Lili; Jiang, Xiling; Li, Hongshan; Kraft, Jeffrey; Liu, Jiang; Charlab, Rosane; Okusanya, Olanrewaju O; Booth, Brian; Pazdur, Richard; Theoret, Marc R; Angelo de Claro, R

FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy

FDA批准摘要:Blinatumomab用于多阶段化疗巩固期治疗B细胞前体急性淋巴细胞白血病

Rabik, Cara A; Wang, Shu; Chadda, Ritu; Przepiorka, Donna; Vallejo, Jonathon; Jiang, Xiling; Theoret, Marc R; de Claro, R Angelo

FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD

FDA批准摘要:阿巴西普用于预防急性GVHD

Norsworthy, Kelly J; Rivera, Donna R; Wynne, Joseph; Zhao, Jian; Konicki, Robyn; Kuzucan, Aida; Vallejo, Jonathon; Leong, Ruby; Okusanya, Olanrewaju O; Booth, Brian; Kluetz, Paul G; Pazdur, Richard; de Claro, R Angelo

FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy

FDA批准摘要:阿沙利单抗适用于体重至少40公斤且既往接受过两线全身治疗后出现慢性移植物抗宿主病(GVHD)的成人和儿童患者

Le, Robert Q; Godder, Kamar; Wang, Jingyan; Collazo, Justin S; Konicki, Robyn; Choe, Moran; Feng, Monica; Przepiorka, Donna; Vallejo, Jonathon; Shah, Ankit; Liu, Jiang; Gehrke, Brenda J; Wilson, Willie; Siegel, Andrea; Wu, Yun; Kuo, Charles Yuan-Chia; Ray, Melissa; Pazdur, Richard; Theoret, Marc R; de Claro, R Angelo

FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation

FDA批准摘要:Ivosidenib用于治疗伴有IDH1突变的复发/难治性骨髓增生异常综合征成人患者

Woods, Ashley C; Pulte, E Dianne; Wang, Xin; Vallejo, Jonathon; Chadda, Ritu; Zheng, Nan; Blanco, Javier G; Dorff, Sarah E; Li, Hongshan; Liu, Jiang; Okusanya, Olanrewaju O; Pazdur, Richard; Theoret, Marc R; de Claro, R Angelo; Norsworthy, Kelly J

Strengthening Health Financing Research to Advance Universal Health Coverage: Gaps, Opportunities, and Policy Imperatives for the Philippines

加强卫生筹资研究以推进全民健康覆盖:菲律宾面临的差距、机遇和政策要务

de Claro, Vergil; Villar, Wanda Louwallin; Sabulao, Michille